Q Bio Gemini - Quantitative Health Platform (software) + Mark I (scanner)
Gemini is Q Bio's software / digital-twin layer; the Mark I is the scanner. Early-stage; confirm pricing and availability.
Q Bio is building whole-body health around a longitudinal model rather than a one-time scan: Gemini is the software / digital-twin layer, the Mark I is the scanner that feeds it. The company is early-stage, so treat pricing and availability as things to confirm directly.
Price: $2,500–$3,500/yr · Verified: 2026-05-04
Q Bio is building whole-body health around a longitudinal model rather than a one-time scan: Gemini is the software / digital-twin layer, the Mark I is the scanner that feeds it. The company is early-stage, so treat pricing and availability as things to confirm directly.
Q Bio is the quantitative-health specialist. Two names matter and they are often conflated: Gemini is Q Bio's software platform - the digital-twin layer that turns measurements into longitudinal trend lines - while the Mark I is the physical scanner that captures the data. Rather than a one-time anatomical scan (Ezra/Prenuvo style), the model is designed for serial measurement: the same person scanned over time, with quantitative measurements (organ volumes, fat distributions, brain volumes) tracked as trends rather than single point-in-time anatomical findings.
The honest caveat is maturity. Q Bio is an early-stage company, and it does not have a clearly productized, broadly bookable consumer offering the way Ezra or Prenuvo do. A membership tier in the $2,500-3,500/year range has been discussed publicly, but pricing and availability are not clearly published and should be confirmed directly with Q Bio before counting on them. For longevity-focused buyers building a quantified-self protocol, the Gemini/Mark I approach is a genuinely different proposition - it is about the trend line, not the snapshot - but it is earlier and less turnkey than the anatomical-scan incumbents.
The trade: less clinical/diagnostic emphasis (Q Bio doesn't surface "incidental findings" the way Ezra/Prenuvo do), narrower availability (fewer scanning locations than Ezra/Prenuvo), early-stage productization, and a membership model rather than per-scan flexibility.
Longevity-focused buyers building a quantified-self protocol with imaging as one input. Family offices running structured annual health programs.
You want a one-time anatomical scan (Ezra/Prenuvo are the right fit), or you specifically want incidental-finding screening (Ezra/Prenuvo emphasize this more).
Specifications
Most often compared with
Featured in these curated stacks
We’ve included this product in 1 editorial bundle - groupings of 4-7 items that work as a system.
Where this fits
Q Bio Gemini (software) + Mark I (scanner) cross-shops across several editorial surfaces on this site: the full brand catalog, the buyer-intent tags this item carries and the price band it qualifies for.
Q Bio Gemini (software) + Mark I (scanner) - buyer FAQ
Q Bio Gemini vs Ezra / Prenuvo - which one for my longevity stack?
Different protocols. Ezra and Prenuvo are anatomical screening - looking for incidental findings, tumors, structural abnormalities. Q Bio is quantitative trend tracking - measuring organ volumes, fat distributions, brain volumes year over year. If your goal is annual "what is wrong" screening, go Ezra / Prenuvo. If your goal is quantified-self longevity tracking with imaging as one input, Q Bio. Some buyers do both - Q Bio for trends, Ezra / Prenuvo every 3-5 years for anatomical screening.
How does the membership pricing work?
Treat this as unconfirmed. A membership in the $2,500-3,500/year range has been discussed publicly and would cover periodic scanning (the Mark I) plus the Gemini software's clinician review and trend dashboard. But Q Bio is early-stage and does not clearly publish consumer pricing or availability, so verify the current cost, what it includes, and whether it is actually bookable in your area directly with Q Bio before planning around it.
Where can I actually get a Q Bio scan?
Availability is limited and worth confirming directly. Q Bio has historically operated around the Bay Area with limited reach - far fewer locations than Ezra or Prenuvo, which run scanners across many US metros. Because Q Bio is early-stage and does not clearly publish a consumer booking footprint, check current locations and whether scanning is actually open to you before planning travel. For buyers outside any service area, access may not be readily available yet.